[PPAR gamma ligand pioglitazone as a therapeutic strategy in nonalcoholic steatohepatitis (NASH)]

Nihon Yakurigaku Zasshi. 2006 Oct;128(4):235-8. doi: 10.1254/fpj.128.235.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Fatty Liver / diet therapy
  • Fatty Liver / drug therapy*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Ligands
  • PPAR gamma / metabolism*
  • Pioglitazone
  • Thiazolidinediones / therapeutic use*

Substances

  • Hypoglycemic Agents
  • Ligands
  • PPAR gamma
  • Thiazolidinediones
  • Pioglitazone